Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi picks corporate voice for new blogging venture

Pharma company's US arm goes beyond discussing diabetes

Sanofi corporate blog

Sanofi US has branched out in its blogging efforts and this week launched Speaking of Sanofi, its first corporate blog.

Managed by the company's corporate reputation and digital communications director Stacy Burch, the blog will include perspectives from Sanofi companies like its vaccine arm Sanofi Pasteur, biotech business Genzyme and animal health company Merial.

Alhough it's still early days for the blog, Sanofi already has an impressive list of contributors planned for Speaking of Sanofi.

These include the head of its North America R&D Hub Marc Bonnefoi, SVP of commercial operations at Sanofi Pasteur Damian Braga and CEO of Genzyme David Meeker.

Outlining Sanofi's plans in an introductory post Burch said Sanofi would also be inviting industry leaders to contribute guest posts.

The new blog adds to the Discuss Diabetes blog Sanofi launched in January 2011 and is further evidence of a resurgence of industry interest in the medium.

The time required to run a blog, certainly when compared with 'lighter' options -at least in terms of writing - like Twitter, has tended to keep their numbers down.

But this year has seen a higher than average number of pharma companies begin blogs, from AstraZeneca's Lab Talk and Lilly's expansion of its LillyPad blog, to Bayer UK's Diabetes Care blog and Boehringer Ingelheim's plans for The Future Just Happened.

7th December 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Seven Stones

Seven Stones is a creative, independent healthcare communications agency focused on delivering what we call our 'total health' proposition -...

Latest intelligence

Paywatch and the market access waters
Understanding and responding to payers’ needs has become priority number one for pharma as it battles the choppy seas of the global health economy...
EY Life Sciences Sector Update
Asia-Pacific and Japan...
A roadmap to strategic drug pricing
The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. Pharma firms must identify products that will benefit from innovative pricing models, and then forge...

Infographics